Treatment of enteroviral meningitis in children: current status and clinical perspectives
Enteroviruses (EVs) are common and significant human pathogens. Currently, there is no vaccine available for most EVs except for poliovirus; furthermore, there is a lack of clinical antiviral drugs for treating EV-related infections. These shortages reveal the need to develop potent compounds for treating enteroviral infections. This article summarizes the development of drugs for EV-related infections based on molecular targets blocking various steps in the viral replication cycle and the use of immune drugs.